Rheumatology Research Review, Issue 75

In this issue:

Tofacitinib shows short-term cardiovascular safety
Secukinumab reduces impact of disease in active AS
ABT-494 promising in RA intolerant to MTX
. . . or TNF inhibition
Tocilizumab in treatment-refractory JIA-associated uveitis
Obesity negatively impacts TNF inhibitors in PsA
Ixekizumab promising in PsA
Long-term productivity costs in early RA
B cell depletion therapy with SBI-087 in active RA

Please login below to download this issue (PDF)

Subscribe